Gastro

жовчний

Органосохраняющие операции в лечении желчнокаменной болезни (лапароскопическая холецистолитотомия)

В отделе хирургии органов пищеварения разработаны, внедрены и активно выполняются органосохраняющие операции на желчном пузыре. Разработан индивидуальный подход к выбору метода лечения желчнокаменной болезни (динамическое наблюдение, литолитическая терапия, органосохраняющие операции на желчном пузыре – лапароскопическая холецистолитотомия, лапароскопическая холецистэктомия) в зависимости от стадии развития болезни, сопутствующей и сочетанной гастроэнтерологической патологии. В зависимости от анатомических особенностей строения […]

Органосохраняющие операции в лечении желчнокаменной болезни (лапароскопическая холецистолитотомия) Read More »

Nutritionist's consultation

Nutritionist’s consultation

“We don’t live to eat, we eat to live” Socrates Since April 2014 в Институте гастроэнтерологии ведет консультативный прием врач-диетолог. Food related issues are on the minds of many people. An increasing number of people are coming to understand that health, good mood and physical form, appearance and quality of life in general depend on

Nutritionist’s consultation Read More »

A set of measures to ensure the treatment and rehabilitation of combatants in the clinic of the Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine

Contact telephones: Reception of the director – (0562) 27-59-16 Reception of the chief physician: (0562) 27-16-18 Fax (0562) 27-05-77 Deputy Chief of Staff: Zavyalova Iryna Yuriivna – 067-727-2040 Resuscitation doctor on duty: (0562) -27-05-59

A set of measures to ensure the treatment and rehabilitation of combatants in the clinic of the Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine Read More »

Crohn's disease

Information for patients with Crohn’s disease (clinical studies)

For patients with Crohn’s disease, the Institute has the opportunity to participate in a clinical trial of the new drug ustekinumab(Stelara). Ustekinumab, which was originally developed to treat psoriasis, has been shown to be extremely effective in treating moderate to severe Crohn’s disease. In a phase III clinical trial by Johnson & Johnson, more than

Information for patients with Crohn’s disease (clinical studies) Read More »

Scroll to Top